A corneal confocal microscopy, independently developed by Gaush Meditech (HKG:2407) unit Gaush Neotech, has been approved by the Jiangsu Medical Products Administration to enter the registration process for innovative products, a Tuesday bourse filing said.
Currently, corneal confocal microscopy has been applied to the diagnostic process and criteria for infectious keratitis.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.